Product Recalls in New York

Product recalls affecting New York — including food, drugs, consumer products, medical devices, and vehicles distributed to New York. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,889 recalls have been distributed to New York in the last 12 months.

55,896 total recalls
2,889 in last 12 months

Showing 24212440 of 13,591 recalls

DrugNovember 9, 2022· ICU Medical Inc

Recalled Item: 0.9% Sodium Chloride Injection Recalled by ICU Medical Inc Due to Lack of...

The Issue: Lack of assurance of sterility: Bags have the potential to leak in the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 5, 2022· Adam's Polishes LLC

Recalled Item: Adam's Polishes ALCOHOL BASED HAND SANITIZER Recalled by Adam's Polishes LLC...

The Issue: CGMP Deviations: Other lots of hand sanitizer are being recalled because...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 5, 2022· Adam's Polishes LLC

Recalled Item: Adam's Polishes ALCOHOL BASED HAND SANITIZER Recalled by Adam's Polishes LLC...

The Issue: Chemical Contamination: FDA analysis found 1 lot of Adam's Polishes ALCOHOL...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugOctober 21, 2022· Viatris Inc

Recalled Item: Carvedilol Tablets Recalled by Viatris Inc Due to Failed Tablet/Capsule...

The Issue: Failed Tablet/Capsule Specifications: Tablets exceeds specification for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 18, 2022· Genentech Inc

Recalled Item: Susvimo (ranibizumab injection) Recalled by Genentech Inc Due to Defective...

The Issue: Defective Delivery System: Commercial implants do not meet the filed...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 18, 2022· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg Recalled by SUN...

The Issue: Presence of Foreign Substance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Lidocaine Hydrochloride Jelly USP Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Tobramycin Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP Deviations:

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Ofloxacin Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP Deviations:

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: GONAK Hypromellose Ophthalmic Demulcent Solution Recalled by Akorn, Inc. Due...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Levofloxacin Ophthalmic Solution 0.5% Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Ketorolac Tromethamine Ophthalmic Solution Recalled by Akorn, Inc. Due to...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Tobramycin Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP Deviations:

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Olopatadine HCl Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Sodium Chloride Ophthalmic Ointment Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Olopatadine HCl Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Erythromycin Ophthalmic Ointment USP Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Betaxolol Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP Deviations:

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Olopatadine HCL Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Proparacaine Hydrochloride Ophthalmic Solution Recalled by Akorn, Inc. Due...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund